FDA Approved: ZIPRASIDONE — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

The FDA approved a supplemental application for ziprasidone from Dr. Reddy's Laboratories Limited, indicating regulatory action on an existing generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

SUPPL AP for ZIPRASIDONE (ZIPRASIDONE)